Line 1: |
Line 1: |
| + | __TOC__ |
| | | |
− | ==Cancer Types== | + | == Breast Tumors WHO Classification == |
| + | :'''Invasive carcinoma of no special type (invasive ductal carcinoma)''' |
| + | :'''Special subtypes''' |
| + | :'''Invasive lobular carcinoma''' |
| + | :: Tubular carcinoma and cribriform carcinoma |
| + | :: Carcinoma with medullary features |
| + | :: Metaplastic carcinoma |
| + | :: Carcinoma with apocrine differentiation |
| + | :: Salivary gland/skin adnexal type tumours |
| + | :: Adenoid cystic carcinoma |
| + | :: Mucoepidermoid carcinoma |
| + | :: Polymorphous carcinoma |
| + | :: Mucinous carcinoma and carcinoma withbignet-ring-cell differentiation |
| + | ::Carcinoma with neuroendocrine features |
| + | :: Invasive papillary carcinoma |
| + | :: Invasive micropapillary carcinoma |
| + | :: Inflammatory carcinoma |
| + | :: Bilateral breast carcinoma and non-synchronous breast carcinoma |
| + | :: Secretory carcinoma |
| + | :: Oncocytic carcinoma |
| + | :: Sebaceous carcinoma |
| + | :: Lipid-rich carcinoma |
| + | :: Glycogen-rich clear cell carcinoma |
| + | :: Acinic cell carcinoma |
| + | :'''Lobular neoplasia''' |
| + | :'''Intraductal proliferative lesions''' |
| + | :: Usual ductal hyperplasia |
| + | :: Columnar cell lesions |
| + | :: Atypical ductal hyperplasia |
| + | :: Ductal carcinoma in situ |
| + | :'''Microinvasive carcinoma''' |
| + | :'''Intraductal papillary lesions''' |
| + | :: Intraductal papilloma |
| + | :: Intraductal papillary carcinoma |
| + | :: Encapsulated papillary carcinoma |
| + | :: Solid papillary carcinoma |
| + | :'''Benign epithelial proliferations''' |
| + | :: Adenosis, sclerosing adenosis and |
| + | :: apocrine adenosis |
| + | :: Microglandular adenosis, |
| + | :: atypical microglandular adenosis and |
| + | :: microglandular adenosis with carcinoma |
| + | :: Radial scar and complex sclerosing lesion |
| + | :: Tubular adenoma |
| + | :: Lactating adenoma |
| + | :: Apocrine adenoma |
| + | :: Ductal adenoma |
| + | :: Pleomorphic adenoma |
| + | :'''Myoepithelial and epithelial–myoepithelial lesions''' |
| + | :: Myoepithelial and epithelial–myoepithelial lesions |
| + | :: Adenomyoepithelioma and adenomyoepithelioma with carcinoma |
| + | :'''Mesenchymal tumours''' |
| + | :: Nodular fasciitis |
| + | :: Benign vascular lesions |
| + | :: Pseudoangiomatous stromal hyperplasia |
| + | :: Myofibroblastoma |
| + | :: Desmoid-type fibromatosis |
| + | :: Inflammatory myofibroblastic tumour |
| + | :: Lipoma |
| + | :: Granular cell tumour and benign peripheral |
| + | :: nerve-sheath tumour |
| + | :: Angiosarcoma |
| + | :: Liposarcoma |
| + | :: Rhabdomyosarcoma |
| + | :: Osteosarcoma |
| + | :: Leiomyoma and leiomyosarcoma |
| + | :'''Fibroepithelial tumours''' |
| + | :: Fibroadenoma |
| + | :: Phyllodes tumour |
| + | :: Hamartoma |
| + | :'''Tumours of the nipple''' |
| + | :: Nipple adenoma |
| + | :: Syringomatous tumour |
| + | :: Paget disease |
| + | :'''Lymphoid and haematopoietic tumours''' |
| + | :: Diffuse large B-cell lymphoma |
| + | :: Burkitt lymphoma |
| + | :: T-cell lymphoma |
| + | :: Extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue |
| + | :: Follicular lymphoma |
| + | :'''Metastases of extramammary malignancies to the breast''' |
| + | :'''Tumors of the male breast''' |
| + | :: Gynaecomastia |
| + | :: Carcinoma of the male breast |
| + | :'''Genetic susceptibility: inherited syndromes''' |
| + | :: Inherited syndromes associated with an increased risk of breast cancer: Introduction |
| + | :: BRCA1 and BRCA2 syndromes |
| + | :: Li-Fraumeni syndrome |
| + | :: Ataxia telangiectasia syndrome |
| + | :: Cowden syndrome |
| + | :: Lynch syndrome |
| + | :: Other breast cancer-predisposing genes |
| + | |
| + | |
| + | |
| + | == Miscellaneous Cancer Types == |
| : [[Acute Lymphoblastic Leukaemia (ALL)]] | | : [[Acute Lymphoblastic Leukaemia (ALL)]] |
| : [[Acute Myeloid Leukaemia (AML)]] | | : [[Acute Myeloid Leukaemia (AML)]] |